Thiogenesis Announces European Consulting and Investor Relations Agreement
Portfolio Pulse from
Thiogenesis Therapeutics has entered into a consulting and investor relations agreement with Bull Markets Media GmbH to expand its shareholder base and contact network in Europe.
February 20, 2025 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Thiogenesis Therapeutics has partnered with Bull Markets Media to expand its European shareholder base and contact network, potentially increasing its visibility and investor interest.
The agreement with Bull Markets Media is likely to enhance Thiogenesis's visibility in Europe, potentially attracting more investors and broadening its shareholder base. This could positively impact the stock price in the short term as investor interest grows.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80